Sign in

CIK 0001360214

  • Large accelerated filer

HARROW, INC.

Sign in to watch
Ticker
HROW
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
450567010
Phone
+1 615-733-4731
Business address
1A BURTON HILLS BLVD, SUITE 200, NASHVILLE, TN
Former names
HARROW HEALTH, INC., Imprimis Pharmaceuticals, Inc., TRANSDEL PHARMACEUTICALS INC, Bywater Resources, Inc
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Open-market buy 10% owner bought 20,000 shares at $9.97 ($199,400)
  6. 4 Open-market buy 10% owner bought 20,000 shares at an average $10.23 ($204,640)
  7. 4 Open-market buy 10% owner bought 29,400 shares at $10.56 ($310,391)
  8. 4 Open-market buy 10% owner bought 50,000 shares at $12.82 ($641,000)
  9. 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 9,000 shares at $11.59 ($104,310)
  10. 4 Open-market buy 10% owner bought 50,600 shares at $9.65 ($488,290)
  11. 4 Exercise or conversion CEO of ImprimisRx acquired 5,000 shares (option exercise)
  12. 4 Exercise or conversion CEO of ImprimisRx acquired 30,000 shares (option exercise)
  13. 4 Exercise or conversion CHIEF FINANCIAL OFFICER acquired 45,000 shares (option exercise)
  14. 4 Exercise or conversion CHIEF EXECUTIVE OFFICER acquired 150,000 shares (option exercise)
  15. 4 Exercise or conversion CHIEF EXECUTIVE OFFICER acquired 15,400 shares (option exercise)
  16. 4 Exercise or conversion CHIEF FINANCIAL OFFICER acquired 7,400 shares (option exercise)
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 3 of 15 · 296 filings